Claritev (NYSE:CTEV – Get Free Report) CFO Douglas Garis sold 9,025 shares of Claritev stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $30.59, for a total value of $276,074.75. Following the completion of the sale, the chief financial officer owned 185,416 shares of the company’s stock, valued at approximately $5,671,875.44. The trade was a 4.64% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Claritev Stock Down 6.8%
NYSE CTEV traded down $2.14 during trading hours on Tuesday, hitting $29.48. The company’s stock had a trading volume of 163,616 shares, compared to its average volume of 160,320. Claritev has a twelve month low of $11.50 and a twelve month high of $73.68. The firm has a market capitalization of $499.69 million, a P/E ratio of -1.73 and a beta of 0.88. The stock has a fifty day moving average of $32.54 and a 200 day moving average of $26.63.
Claritev (NYSE:CTEV – Get Free Report) last released its earnings results on Friday, August 7th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of ($4.10) by $5.51. The business had revenue of $257.48 million for the quarter. On average, analysts predict that Claritev will post -15.13 earnings per share for the current year.
Wall Street Analyst Weigh In
View Our Latest Analysis on CTEV
Institutional Investors Weigh In On Claritev
Several hedge funds have recently modified their holdings of the stock. Public Investment Fund acquired a new stake in Claritev in the 2nd quarter valued at $43,703,438. Bank of America Corp DE raised its holdings in Claritev by 146.6% during the first quarter. Bank of America Corp DE now owns 97,795 shares of the company’s stock worth $1,598,000 after buying an additional 58,133 shares during the last quarter. Arini Captial Management Ltd bought a new position in shares of Claritev in the fourth quarter valued at $64,291,000. Beach Point Capital Management LP lifted its stake in shares of Claritev by 77.4% in the fourth quarter. Beach Point Capital Management LP now owns 755,002 shares of the company’s stock valued at $32,276,000 after buying an additional 329,424 shares in the last quarter. Finally, Engineers Gate Manager LP acquired a new position in shares of Claritev during the second quarter valued at about $245,000. 87.15% of the stock is owned by hedge funds and other institutional investors.
Claritev Company Profile
Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency and quality. Led by deeply experienced associates, data scientists, and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources from over 40 years of claims repricing. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design.
Read More
- Five stocks we like better than Claritev
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
- Oura’s $15.6 Billion IPO Is Betting Investors See More Than a Smart Ring
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
Receive News & Ratings for Claritev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Claritev and related companies with MarketBeat.com's FREE daily email newsletter.
